Compare ILMN & TOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ILMN | TOL |
|---|---|---|
| Founded | 1998 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.4B | 15.7B |
| IPO Year | 2000 | 1994 |
| Metric | ILMN | TOL |
|---|---|---|
| Price | $129.99 | $142.54 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 17 | 16 |
| Target Price | $124.24 | ★ $164.07 |
| AVG Volume (30 Days) | ★ 1.3M | 1.1M |
| Earning Date | 04-30-2026 | 05-19-2026 |
| Dividend Yield | N/A | ★ 0.71% |
| EPS Growth | ★ 170.87 | N/A |
| EPS | ★ 5.45 | 2.19 |
| Revenue | $4,343,000,000.00 | ★ $7,143,258,000.00 |
| Revenue This Year | $6.52 | N/A |
| Revenue Next Year | $5.60 | $5.95 |
| P/E Ratio | ★ $23.37 | $64.33 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $69.88 | $90.78 |
| 52 Week High | $155.53 | $168.36 |
| Indicator | ILMN | TOL |
|---|---|---|
| Relative Strength Index (RSI) | 56.32 | 54.15 |
| Support Level | $127.99 | $141.72 |
| Resistance Level | $136.86 | $150.45 |
| Average True Range (ATR) | 5.18 | 3.89 |
| MACD | 0.53 | 1.44 |
| Stochastic Oscillator | 79.63 | 91.60 |
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Toll Brothers Inc is the luxury homebuilder in the USA, operating in over 60 markets across 24 states. The Fort Washington, Pennsylvania-headquartered homebuilder caters to affluent first-time, move-up, active-adult, and second-homebuyers. Toll Brothers has shifted in recent years to a greater mix of speculative, or "quick move-in" homes. The homebuilder has also expanded its price points, with a greater emphasis on "affordable luxury. Traditional homebuilding accounts for the majority of Toll Brothers' earnings, but the firm also offers ancillary mortgage, title, insurance, and other services.